ARMISTICE CAPITAL, LLC purchased 0.7% of their position (312K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $274.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/20/2022ACC: 0000899243-22-002693
Director10% Owner
Since Jun 2018
+312K
Net shares
Net buyer
$274.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
312K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+206.30K
Price / share
$0.88
Trade value
$182.22K
% of position
0.4%
1/18/2022
46.10M→46.31M
Common Stock
Indirect
Shares
+93.70K
Price / share
$0.88
Trade value
$82.05K
% of position
0.2%
1/19/2022
46.31M→46.40M
Common Stock
Indirect
Shares
+12K
Price / share
$0.85
Trade value
$10.21K
% of position
0.0%
1/20/2022
46.40M→46.41M
Total
Net shares
+312K
Net value
$274.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/18/2022 | P · Purchase | +206.30K | $0.88 | $182.22K | 0.4% | 46.10M | 46.31M |
| Common Stock Indirect | 1/19/2022 | P · Purchase | +93.70K | $0.88 | $82.05K | 0.2% | 46.31M | 46.40M |
| Common Stock Indirect | 1/20/2022 | P · Purchase | +12K | $0.85 | $10.21K | 0.0% | 46.40M | 46.41M |
| Total | +312K | $274.49K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported